1 completed, 1 recruiting, 1 unknown. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Recruiting 1, Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow Capillary Malformations, Congenital, 1: new trials by email Literature Review of Capillary Malformations, Congenital, 1 trials Research Report on Capillary Malformations, Congenital, 1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Randomized Placebo Controlled Study of Triamcinolone Acetonide Extended Release Injection for Thumb (CMC) Osteoarthritis Triamcinolone Acetonide extended release suspension - Carpometacarpal (CMC) Osteoarthritis | Phase 2 | Recruiting | Marie Badalamente | 30 | 2023-11-21 | 2024-02-01 |
| Electrosclerotherapy for Capillary Malformations Electrosclerotherapy, Intralesional bleomycin injection - Capillary Malformations, Vascular Malformations | Phase 2 | Unknown | Sophie Horbach | 20 | 2016-11-01 | 2017-06-27 |
| Double-Blind,Randomized,Placebo-Controlled Efficacy & Safety Study of EUFLEXXA™ for Treatment of OA of the First CMC sodium hyaluronate, placebo - Osteoarthritis | Phase 2 / Phase 3 | Completed | Ferring Pharmaceuticals | 79 | 2006-12-01 | 2011-05-19 |
Osteoarthritis (2) · Vascular Malformations (1)
Arthritis (2) · Joint Diseases (2) · Musculoskeletal Diseases (2) · Rheumatic Diseases (2) · Cardiovascular Abnormalities (1) · Cardiovascular Diseases (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)
Ferring Pharmaceuticals (1) · Marie Badalamente (1) · Sophie Horbach (1)
United States (2) · Netherlands (1)